Published in BMC Complement Altern Med on October 18, 2016
Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report (2008) 19.25
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature (2006) 9.36
Identification of a nuclear receptor for bile acids. Science (1999) 7.81
Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell (2000) 6.48
Bile salt biotransformations by human intestinal bacteria. J Lipid Res (2005) 6.00
Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab (2013) 4.88
Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell (1999) 4.76
Bile acids: regulation of synthesis. J Lipid Res (2009) 4.31
Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev (2010) 2.97
The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med (2000) 2.31
Diet, anaerobic bacterial metabolism, and colon cancer: a review of the literature. J Clin Gastroenterol (2005) 2.08
Increased serum deoxycholic acid levels in men with colorectal adenomas. Gastroenterology (1993) 2.08
The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells. Hepatology (2007) 1.69
Effect of molecular structure on bile acid-induced alterations in absorptive function, permeability, and morphology in the perfused rabbit colon. J Lab Clin Med (1979) 1.57
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. PLoS One (2012) 1.46
Effects of feeding bile acids and a bile acid sequestrant on hepatic bile acid composition in mice. J Lipid Res (2010) 1.45
Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 1.42
Organic anion-transporting polypeptide 1b2 (Oatp1b2) is important for the hepatic uptake of unconjugated bile acids: Studies in Oatp1b2-null mice. Hepatology (2010) 1.29
Berberine: a potential phytochemical with multispectrum therapeutic activities. Expert Opin Investig Drugs (2010) 1.27
Counter-regulatory role of bile acid activated receptors in immunity and inflammation. Curr Mol Med (2010) 1.24
Nitric oxide and acid induce double-strand DNA breaks in Barrett's esophagus carcinogenesis via distinct mechanisms. Gastroenterology (2007) 1.23
Cytochrome P450s in the synthesis of cholesterol and bile acids--from mouse models to human diseases. FEBS J (2011) 1.22
Berberine suppresses TNF-alpha-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells. Molecules (2008) 1.19
Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase. Cardiovasc Res (2009) 1.17
Berberine Moderates Glucose and Lipid Metabolism through Multipathway Mechanism. Evid Based Complement Alternat Med (2010) 1.13
Dose-response of five bile acids on serum and liver bile Acid concentrations and hepatotoxicty in mice. Toxicol Sci (2011) 1.12
Bile acids: short and long term effects in the intestine. Scand J Gastroenterol (2010) 1.12
Bile acid metabolism in mammals. I. Bile acid-induced intrahepatic cholestasis. Lab Invest (1971) 1.10
Cholestasis in rats induced by taurolithocholate. Nature (1966) 1.09
Hepatobiliary excretion of berberine. Drug Metab Dispos (2004) 1.08
Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: involvement of NF-κB signaling pathway. Mol Cell Endocrinol (2010) 1.07
Deconjugation of bile salts by Bacteroids and Clostridium. Microbiol Immunol (1981) 1.06
Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism. J Intern Med (2013) 1.02
Dysfunction of organic anion transporting polypeptide 1a1 alters intestinal bacteria and bile acid metabolism in mice. PLoS One (2012) 1.00
Deoxycholate induces DNA damage and apoptosis in human colon epithelial cells expressing either mutant or wild-type p53. Int J Biochem Cell Biol (2001) 1.00
Bile acid receptors in non-alcoholic fatty liver disease. Biochem Pharmacol (2013) 0.99
Effect of various antibiotics on modulation of intestinal microbiota and bile acid profile in mice. Toxicol Appl Pharmacol (2014) 0.97
Modulating gut microbiota as an anti-diabetic mechanism of berberine. Med Sci Monit (2011) 0.95
Function of the microbiota. Best Pract Res Clin Gastroenterol (2013) 0.92
Berberine inhibits cyclin D1 expression via suppressed binding of AP-1 transcription factors to CCND1 AP-1 motif. Acta Pharmacol Sin (2008) 0.86
Tauroursodeoxycholate and tauro-beta-muricholate exert cytoprotection by reducing intrahepatocyte taurochenodeoxycholate content. Hepatology (1993) 0.84
Berberine and plant stanols synergistically inhibit cholesterol absorption in hamsters. Atherosclerosis (2009) 0.83
Rational design of berberine-based FtsZ inhibitors with broad-spectrum antibacterial activity. PLoS One (2014) 0.82
Growth-inhibiting effects of Coptis japonica root-derived isoquinoline alkaloids on human intestinal bacteria. J Agric Food Chem (1999) 0.82
Variation of serum bile acids in patients with colorectal adenomas during a one-year follow-up. Digestion (1994) 0.79
[The effect of berberine chloride on the intestinal flora of infants]. Arzneimittelforschung (1961) 0.77
The effect of berberine on bilirubin excretion in the rat. Comp Med East West (1977) 0.77
Effect of tauro-alpha-muricholate and tauro-beta-muricholate on oestradiol-17 beta-glucuronide-induced cholestasis in rats. J Gastroenterol Hepatol (1997) 0.76